產(chǎn)品詳情
簡單介紹：
Anti-BIG1抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-BIG1抗體用于**組化實驗,WB實驗,相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-BIG1
Cat. Number:
Anti-BIG1抗體KL-12866R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Guanine nucleotide-exchange proteins (GEPs) accelerate replacement of bound GDP with GTP and thereby activate ADP-ribosylation factors (ARFs), a family of guanine nucleotide-binding proteins that play an important role inAnti-BIG1抗體 intracellular vesicular trafficking. GEPs comprise two major families, large GEPs that are inhibited by brefeldin A (BFA), a protein that effects Golgi structure and a group of smaller GEPs that are insenstive to BFA. Two genes for GEPs found on human chromosomes 8 and 20 encode BFA sensitive GEPs designated BIG1 and BIG2. Both GEPS contain a sec7 domain that is responsible for their brefeldin inhibition and also their catalytic activity. In vivo, BIG1 and BIG2 exist in macromolecular complexes that move between the Golgi membranes and cytosol. BIG2 associates with PKA regulatory subunits, implying that BIG2 may act as an A kinase-anchoring protein (AKAP) that could coordinate the cAMP and ARF regulatory pathways.
Also known as:
ARFGEF1; ADPribosylation Anti-BIG1抗體factor guanine nucleotide exchange factor 1(brefeldin A inhibited); ARFGEP1; Brefeldin A inhibited GEP 1; Brefeldin A inhibited guanine nucleotide exchange protein 1; p200 ARF GEP1; p200 ARF guanine nucleotide exchange factor; BIG1_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human BIG1/ARFGEF1.
●
Predicted Molecular Weight: 209kDa.
Storage:
Shipped at 4℃, Store at -20℃Anti-BIG1抗體 (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutionsAnti-BIG1抗體 must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutionsAnti-BIG1抗體 must be determined by the end user.
kl365Hu01 葡萄糖激酶調(diào)節(jié)蛋白(GKRP)多克隆抗體 Polyclonal Antibody to Glucokinase Regulatory Protein (GKRP)
kl366Hu01 血管內(nèi)皮鈣黏蛋白(CDH5)多克隆抗體 Polyclonal Antibody to Cadherin 5 (CDH5)
kl366Mu01 血管內(nèi)皮鈣黏蛋白(CDH5)多克隆抗體 Polyclonal Antibody to Cadherin 5 (CDH5)
kl367Hu01 血管內(nèi)皮生長因子受體2(VEGFR2)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
kl367Mu01 血管內(nèi)皮生長因子受體2(VEGFR2)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
kl367Ra01 血管內(nèi)皮生長因子受體2(VEGFR2)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
kl368Hu01 肝配蛋白A受體1(EPHA1)多克隆抗體 Polyclonal Antibody to Ephrin Type A Receptor 1 (EPHA1)
kl370Hu01 乳酸脫氫酶A(LDHA)多克隆抗體 Polyclonal Antibody to Lactate Dehydrogenase A (LDHA)
kl370Ra01 乳酸脫氫酶A(LDHA)多克隆抗體 Polyclonal Antibody to Lactate Dehydrogenase A (LDHA)
kl371Hu01 轉(zhuǎn)醛縮酶(TALDO1)多克隆抗體 Polyclonal Antibody to Transaldolase (TALDO1)
kl371Ra01 轉(zhuǎn)醛縮酶(TALDO1)多克隆抗體 Polyclonal Antibody to Transaldolase (TALDO1)
kl372Hu01 鱗狀細胞癌抗原1(SCCA1)多克隆抗體 Polyclonal Antibody to Squamous Cell Carcinoma Antigen 1 (SCCA1)
kl373Hu01 防御素β1(DEFβ1)多克隆抗體 Polyclonal Antibody to Defensin Beta 1 (DEFb1)
kl373Mu01 防御素β1(DEFβ1)多克隆抗體 Polyclonal Antibody to Defensin Beta 1 (DEFb1)
kl373Po01 防御素β1(DEFβ1)多克隆抗體 Polyclonal Antibody to Defensin Beta 1 (DEFb1)
kl373Ra01 防御素β1(DEFβ1)多克隆抗體 Polyclonal Antibody to Defensin Beta 1 (DEFb1)
